熱門資訊> 正文
Allarity Therapeutics宣布新任首席财务官
2024-09-13 21:11
- Allarity Therapeutics (NASDAQ:ALLR) on Friday announced the appointment of Alex Epshinsky as the company’s new Chief Financial Officer.
- Most recently, Epshinsky served as controller at Avenue Therapeutics, with prior key financial roles at Aruvant and Turnstone Biologics.
- ALLR +0.96% premarket to $2.9078.
- Source: Press Release
More on Allarity Therapeutics
- Allarity Therapeutics executes 1-for-30 reverse stock split
- Seeking Alpha’s Quant Rating on Allarity Therapeutics
- Historical earnings data for Allarity Therapeutics
- Financial information for Allarity Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
